Prolonged Consumption of A2 β-Casein Milk Reduces Symptoms Compared to A1 and A2 β-Casein Milk in Lactose Maldigesters: A Two-Week Adaptation Study
Nutrients · 2024
DOI: 10.3390/nu16121963 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2024. Verfasst von Monica Ramakrishnan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition Science, College of Health and Human Sciences, Purdue University, West Lafayette, IN 47907, USA. Hauptthemen laut MEDLINE: Lactose Intolerance, Caseins, Milk, Cross-Over Studies. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, The a2 milk company ltd, The a2 Milk Company Ltd..
Abstract (Originalsprache)
Approximately 30% of milk protein is β-casein. We aimed to determine whether lactose maldigesters who chronically consumed two cups of A1/A2 milk (containing 75% A1 β-casein and 25% A2 β-casein) would adapt to have fewer intolerance symptoms, lower serum inflammatory markers, and/or altered glutathione levels similar to those consuming A2 milk (containing 100% A2 β-casein). A double-blinded, randomized, crossover trial was conducted. Sixteen confirmed lactose maldigesters consumed 250 mL of A1/A2 milk and A2 milk twice daily with meals for two weeks. At the end of the adaptation period on day 15, lactose maldigestion was measured after a challenge with the same milk used for adaptation (0.5 g of lactose per kg of body weight) with a hydrogen breath test. Fecal urgency was higher during the two-week consumption of A1/A2 milk compared to A2 milk (p = 0.04, n = 16). Bloating (p = 0.03, n = 16) and flatulence (p = 0.02, n = 16) were also higher on the 15th day with A1/A2 milk compared to A2 milk challenge. However, day-to-day symptoms, hydrogen, serum inflammatory markers, and antioxidant concentrations were not different after A1/A2 and A2 milk consumption adaptation periods. Adaptation over two weeks did not improve lactose digestion or tolerance of A1/A2 milk to match that of A2 milk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nutrition Science, College of Health and Human Sciences, Purdue University, West Lafayette, IN 47907, USA.
ORCID-Profile: Dennis A Savaiano
Förderung
- NIDDK NIH HHS
- The a2 milk company ltd
- The a2 Milk Company Ltd.
Zitieren
APA
Ramakrishnan, M., Mysore Saiprasad, S., & Savaiano, D. A. (2024). Prolonged Consumption of A2 β-Casein Milk Reduces Symptoms Compared to A1 and A2 β-Casein Milk in Lactose Maldigesters: A Two-Week Adaptation Study. Nutrients. https://doi.org/10.3390/nu16121963
Vancouver
Ramakrishnan M, Mysore Saiprasad S, Savaiano DA. Prolonged Consumption of A2 β-Casein Milk Reduces Symptoms Compared to A1 and A2 β-Casein Milk in Lactose Maldigesters: A Two-Week Adaptation Study. Nutrients. 2024. doi:10.3390/nu16121963
BibTeX
@article{Ramakrishnan2024,
author = {Ramakrishnan, Monica and Mysore Saiprasad, Sindusha and Savaiano, Dennis A},
title = {Prolonged Consumption of A2 β-Casein Milk Reduces Symptoms Compared to A1 and A2 β-Casein Milk in Lactose Maldigesters: A Two-Week Adaptation Study},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16121963}
}
EUVIMED